IMiD/Anti-CD20 combo induces complete responses in r/r NHLJuly 19, 2017Mantle Cell LymphomaFollicular Lymphoma
Copanlisib makes inroads against relapsed/refractory follicular lymphomaJuly 11, 2017Follicular Lymphoma
Pembrolizumab + rituximab boost response rates in relapsed follicular lymphomaJune 26, 2017Follicular Lymphoma
FDA approves rituximab + hyaluronidase human for FL, DLBCL, and CLLJune 22, 2017CLLFollicular Lymphoma
Lenalidomide-rituximab induces high CR rate in untreated follicular lymphomaJune 21, 2017Follicular Lymphoma
GALEN safe and effective in relapsed and refractory follicular lymphomaJune 20, 2017Follicular Lymphoma
